Clinical Trial Update: Development of a Breath Test for Monitoring Patients With Liver Disease [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating a breath test for monitoring liver disease in patients with fatty liver disease and cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Nonalcoholic Fatty Liver Disease

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Fatty Liver, Cirrhosis | Phase 3 | Status: COMPLETED